Substantial impact of 68Ga-PSMA-PET/CT on the radiotherapeutic approach for prostate cancer

被引：0
作者：
Schmidt-Hegemann, N. [1 ]
Eze, C. [1 ]
Li, M. [1 ]
Rogowski, P. [1 ]
Schaefer, C. [1 ]
Stief, C. [2 ]
Ganswindt, U. [3 ]
Bartenstein, P. [4 ]
Belka, C. [1 ]
Ilhan, H. [4 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiat Oncol, Munich, Germany
[2] Univ Hosp Munich, Dept Urol, Klin & Poliklin Urol, Munich, Germany
[3] Med Univ Innsbruck, Dept Therapeut Radiol & Oncol, Innsbruck, Austria
[4] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)31935-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1515
引用
收藏
页码：S820 / S820
页数：1
相关论文
共 50 条
  • [31] The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer
    Hoffmann, Manuela A.
    Wieler, Helmut J.
    Baues, Christian
    Kuntz, Nicholas J.
    Richardsen, Ines
    Schreckenberger, Mathias
    [J]. UROLOGY, 2019, 130 : 1 - 12
  • [32] 68Ga-PSMA PET/CT; current impact on management in prostate cancer
    Intema, F.
    Kooistra, A.
    Lont, A. P.
    Hendriks, L. P. J.
    Esser, J. P.
    Lange, R.
    de Klerk, J. M. H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S707 - S707
  • [33] Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer
    Algin, Efnan
    Okudan, Berna
    Acikgoz, Yusuf
    Sayan, Haluk
    Bal, Oznur
    Seven, Bedri
    [J]. CURRENT MEDICAL IMAGING, 2024, 20
  • [34] Predicting 68Ga-PSMA-PET–CT positivity for recurrent disease
    Louise Stone
    [J]. Nature Reviews Urology, 2018, 15 : 137 - 137
  • [35] Impact of definitive radiotherapy on metabolic response measured with 68Ga-PSMA-PET/CT in patients with intermediate-risk prostate cancer
    Onal, Cem
    Guler, Ozan C.
    Torun, Nese
    Elmali, Aysenur
    Sutera, Philip
    Deek, Matthew P.
    Reyhan, Mehmet
    Yavuz, Melek
    Tran, Phuoc T.
    [J]. PROSTATE, 2024, 84 (15) : 1366 - 1374
  • [36] Mesorectal Lymph Node Metastases as Index Lesion in 68Ga-PSMA-PET/CT Imaging for Recurrent Prostate Cancer
    Leitsmann, Conrad
    Schmid, Marianne
    Sahlmann, Carsten-Oliver
    Trojan, Lutz
    Strauss, Arne
    [J]. FRONTIERS IN SURGERY, 2021, 8
  • [37] Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer
    Gawish, Ahmed
    Abdulayev, Nurlan
    El-Arayed, Souhir
    Rollich, Burkard
    Ochel, Hans-Joachim
    Brunner, Thomas B.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (04) : 987 - 994
  • [38] Optimizing treatment for Gleason 10 prostate cancer: radiation dose escalation and 68Ga-PSMA-PET/CT staging
    Onal, Cem
    Guler, Ozan Cem
    Demirhan, Birhan
    Erpolat, Petek
    Elmali, Aysenur
    Yavuz, Melek
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2025,
  • [39] Reply: "The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer"
    Hoffmann, Manuela A.
    Wieler, Helmut J.
    Baues, Christian
    Kuntz, Nicholas J.
    Richardsen, Ines
    Schreckenberger, Mathias
    [J]. UROLOGY, 2019, 131 : 262 - 263
  • [40] Impact of Ga-68 PSMA PET/CT on radiation treatment planning of prostate cancer
    Schwarzenboeck, S. M.
    Schubert, L.
    Rennau, H.
    Kurth, J.
    Krause, B. J.
    Hildebrandt, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S165 - S166
12345